United States · FDA National Drug Code directory
human papillomavirus quadrivalent (types 6, 11, 16, and 18)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63552-212_2df92a73-f81c-646f-e063-6294a90a1c88
- Product NDC
- 63552-212
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- human papillomavirus quadrivalent (types 6, 11, 16, and 18)
- Labeler
- Patheon Manufacturing Services LLC
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20241223
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN — 20 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN — 40 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN — 20 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN — 40 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 388 VIAL, SINGLE-DOSE in 1 TRAY (63552-212-00) / .5 mL in 1 VIAL, SINGLE-DOSE (63552-212-05) · 63552-212-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →